Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines

dc.authorid0000-0002-9096-1512
dc.authorid0000-0002-1423-0435
dc.contributor.authorOnur Sucu, Bilgesu
dc.contributor.authorSavluğ İpek, Özgecan
dc.contributor.authorÖzdatlı Kurtuluş, Şükran
dc.contributor.authorYazıcı, Büşra Emine
dc.contributor.authorKarakaş, Nihal
dc.contributor.authorGüzel, Mustafa
dc.date.accessioned2019-12-25T11:43:30Z
dc.date.available2019-12-25T11:43:30Z
dc.date.issued2019
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Hizmetleri Meslek Yüksekokulu, Eczane Hizmetleri Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Rejeneratif ve Restoratif Tıp Araştırmaları Merkezi (REMER)
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyoloji Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Farmakoloji Ana Bilim Dalı
dc.description.abstractWarburg hypothesized that the energy consumption of cancer cells is different than the normal cells. When compared to normal conditions, cancer cells do not undergo tricarboxylic acid (TCA) cycle therefore resulting in more lactate in the cells. Glycolysis pathway is a way of cancer cells to provide energy. The first step in glycolysis is the phosphorylation of glucose to glucose-6-phosphate. This reaction is catalyzed by the hexokinase-II enzyme (HK-II) which is known to be overexpressed in tumor cells. The feeding of cancer cells can be prevented by inhibiting the hexokinase-II enzyme in the first step of aerobic glycolysis. In literature, Methyl Jasmonate (MJ) is known as a Hexokinase-II inhibitor since it disposes VDAC and HK-II interaction on mitochondrial membrane. In our study, we aimed to increase the activity by synthesizing the novel MJ analogues with appropriate modifications. Here we report Hexokinase-2 enzyme and cell viability study results in different cancer cells. Based on the three different cancer cell lines we investigated, our novel MJ analogues proved to be more potent than the original molecule. Thus this research may provide more efficacious/ novel HK-II inhibitors and may shed light to develop new anti-cancer agents.
dc.description.sponsorshipTürkiye Bilimsel ve Teknolojik Araştırma Kurumu (TÜBİTAK)en_US
dc.identifier.citationOnur Sucu, B., Savluğ İpek, Ö., Özdatlı Kurtuluş, Ş., Yazıcı, B. E., Karakaş, N. ve Güzel, M. (2019). Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines. Bioorganic Chemistry, 91. https://doi.org/10.1016/j.bioorg.2019.103146
dc.identifier.doi10.1016/j.bioorg.2019.103146
dc.identifier.issn1090-2120
dc.identifier.issn0045-2068
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.bioorg.2019.103146
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4682
dc.identifier.volume91
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAcademic Press Inc Elsevier Science
dc.relation.ecinfo:eu-repo/grantAgreement/TUBITAK/215S890
dc.relation.ispartofBioorganic Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCancer Therapy
dc.subjectAerobic Glycolysis
dc.subjectWarburg Effect
dc.subjectHexokinase-II Inhibition
dc.subjectMethyl Jasmonate
dc.subjectNovel Drug Discovery and Development
dc.titleSynthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
onursucu-bilgesu(2019).pdf
Boyut:
1.33 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: